Viewpoint

European Journal of Human Genetics (2007) 15, 260–263. doi:10.1038/sj.ejhg.5201753; published online 13 December 2006

Are genome-wide association studies all that we need to dissect the genetic component of complex human diseases?

Catherine Bourgain1, Emmanuelle Génin1, Nancy Cox2,3 and Françoise Clerget-Darpoux1

  1. 1INSERM U535, University Paris Sud, Villejuif F-94817, France
  2. 2Department of Medicine, University of Chicago, Chicago, IL, USA
  3. 3Department of Human Genetics, University of Chicago, Chicago, IL, USA

Correspondence: Dr C Bourgain, INSERM U535, University Paris XI, Genetique Epidemiologique et Structure des Populations Humaines, Hopital Paul Brousse, Batiment Leriche, B.P. 1000, Villejuif, Cedex 94817, France. Tel: +33 1 45 59 53 85; Fax: + 33 1 45 59 53 31; E-mail: bourgain@vjf.inserm.fr

Received 1 June 2006; Revised 12 September 2006; Accepted 27 October 2006; Published online 13 December 2006.

Top

Abstract

With the availability of dense maps of anonymous and frequent SNPs spanning the whole human genome, genome-wide association studies are now becoming a reality. In this paper, we discuss the utility of these approaches to detect genetic risk variants involved in complex disease susceptibility and, in the best case scenario where a signal is detected, how helpful it will be to the understanding of the pathological process.

Keywords:

genome-wide association study, power, modelling

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Research Highlights

Nature Genetics News and Views (01 Apr 2005)

Extra navigation

.

naturejobs

ADVERTISEMENT